These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 1513859

  • 1. Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens.
    Hooks MS, Jones DN, Justice JB, Holtzman SG.
    Pharmacol Biochem Behav; 1992 Aug; 42(4):765-70. PubMed ID: 1513859
    [Abstract] [Full Text] [Related]

  • 2. Effects of naloxone on amphetamine induced striatal dopamine release in vivo: a microdialysis study.
    Feigenbaum JJ, Howard SG.
    Life Sci; 1997 Aug; 60(19):1659-68. PubMed ID: 9129121
    [Abstract] [Full Text] [Related]

  • 3. Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine.
    Schad CA, Justice JB, Holtzman SG.
    Eur J Pharmacol; 1995 Feb 24; 275(1):9-16. PubMed ID: 7774666
    [Abstract] [Full Text] [Related]

  • 4. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats.
    Robinson TE, Jurson PA, Bennett JA, Bentgen KM.
    Brain Res; 1988 Oct 18; 462(2):211-22. PubMed ID: 2847849
    [Abstract] [Full Text] [Related]

  • 5. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
    Sharp T, Zetterström T, Ljungberg T, Ungerstedt U.
    Brain Res; 1987 Jan 20; 401(2):322-30. PubMed ID: 3815099
    [Abstract] [Full Text] [Related]

  • 6. Effect of naloxone on dopamine uptake and release in vitro in the striatum.
    Feigenbaum JJ, Yanai J, Iser C, Klawans H.
    Neuropsychobiology; 1984 Jan 20; 11(2):94-7. PubMed ID: 6483167
    [Abstract] [Full Text] [Related]

  • 7. Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics.
    Kuczenski R, Segal DS, Aizenstein ML.
    J Neurosci; 1991 Sep 20; 11(9):2703-12. PubMed ID: 1715389
    [Abstract] [Full Text] [Related]

  • 8. A glutamate-dopamine interaction in the persistent enhanced response to amphetamine in nucleus accumbens core but not shell following a single restraint stress.
    Pacchioni AM, Cador M, Bregonzio C, Cancela LM.
    Neuropsychopharmacology; 2007 Mar 20; 32(3):682-92. PubMed ID: 16641941
    [Abstract] [Full Text] [Related]

  • 9. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies.
    Wan RQ, Giovanni A, Kafka SH, Corbett R.
    Behav Brain Res; 1996 Aug 20; 78(2):211-23. PubMed ID: 8864054
    [Abstract] [Full Text] [Related]

  • 10. Opioid influence on some aspects of stereotyped behavior induced by repeated amphetamine treatment.
    Cancela LM, Artinián J, Fulginiti S.
    Pharmacol Biochem Behav; 1988 Aug 20; 30(4):899-904. PubMed ID: 2976168
    [Abstract] [Full Text] [Related]

  • 11. Individual differences in amphetamine sensitization: dose-dependent effects.
    Hooks MS, Jones GH, Neill DB, Justice JB.
    Pharmacol Biochem Behav; 1992 Jan 20; 41(1):203-10. PubMed ID: 1539070
    [Abstract] [Full Text] [Related]

  • 12. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens.
    Heidbreder C, Feldon J.
    Synapse; 1998 Aug 20; 29(4):310-22. PubMed ID: 9661249
    [Abstract] [Full Text] [Related]

  • 13. Previous exposure to amphetamine enhances the subsequent locomotor response to a D1 dopamine receptor agonist when glutamate reuptake is inhibited.
    Kim JH, Perugini M, Austin JD, Vezina P.
    J Neurosci; 2001 Mar 01; 21(5):RC133. PubMed ID: 11222671
    [Abstract] [Full Text] [Related]

  • 14. The effects of apomorphine and D-amphetamine on striatal c-Fos expression in Sprague-Dawley and Long Evans rats and their F1 progeny.
    Saint Marie RL, Neary AC, Shoemaker JM, Swerdlow NR.
    Brain Res; 2006 Nov 13; 1119(1):203-14. PubMed ID: 16979142
    [Abstract] [Full Text] [Related]

  • 15. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW.
    J Neurochem; 1988 Feb 13; 50(2):346-55. PubMed ID: 2447237
    [Abstract] [Full Text] [Related]

  • 16. The influence of nicotine pretreatment on mesoaccumbens dopamine overflow and locomotor responses to D-amphetamine.
    Birrell CE, Balfour DJ.
    Psychopharmacology (Berl); 1998 Nov 13; 140(2):142-9. PubMed ID: 9860104
    [Abstract] [Full Text] [Related]

  • 17. Amphetamine-induced effects on neuropeptide Y in the rat brain.
    Obuchowicz E, Turchan J, Przewłocki R, Herman ZS.
    Pharmacol Rep; 2005 Nov 13; 57(3):321-9. PubMed ID: 15985714
    [Abstract] [Full Text] [Related]

  • 18. Comparing nucleus accumbens and dorsal striatal dopamine responses to self-administered cocaine in naïve rats.
    D'Souza MS, Duvauchelle CL.
    Neurosci Lett; 2006 Nov 13; 408(2):146-50. PubMed ID: 16979294
    [Abstract] [Full Text] [Related]

  • 19. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
    Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD.
    Psychopharmacology (Berl); 2003 Feb 13; 165(4):359-69. PubMed ID: 12491026
    [Abstract] [Full Text] [Related]

  • 20. Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects.
    Carpenter C, Zestos AG, Altshuler R, Sorenson RJ, Guptaroy B, Showalter HD, Kennedy RT, Jutkiewicz E, Gnegy ME.
    Neuropsychopharmacology; 2017 Sep 13; 42(10):1940-1949. PubMed ID: 28492278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.